Valeant Pharma to save more from Bausch & Lomb deal (Reuters) - Canada's Valeant Pharmaceuticals International Inc (TOR:VRX) (NYS:VRX) said it would cut 10 to 15 percent jobs after buying contact lens maker Bausch & Lomb and added that cost savings may ...
July 29, 2013 - Reuters via Yahoo! Finance